GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Total Stockholders Equity

Aroa Biosurgery (ASX:ARX) Total Stockholders Equity : A$87.09 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Total Stockholders Equity?

Aroa Biosurgery's Total Stockholders Equity for the quarter that ended in Mar. 2024 was A$87.09 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Aroa Biosurgery's Book Value per Share for the quarter that ended in Mar. 2024 was A$0.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Aroa Biosurgery's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.08.


Aroa Biosurgery Total Stockholders Equity Historical Data

The historical data trend for Aroa Biosurgery's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Total Stockholders Equity Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Total Stockholders Equity
62.86 53.69 93.40 95.38 87.09

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial 93.40 89.75 95.38 90.25 87.09

Aroa Biosurgery  (ASX:ARX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Aroa Biosurgery's Book Value per Share for the quarter that ended in Mar. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Aroa Biosurgery's Debt-to-Equity for the quarter that ended in Mar. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aroa Biosurgery Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Aroa Biosurgery (ASX:ARX) Business Description

Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines